•  
  •  
  •  
  •  

2026-07-21 17:54:28

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Nureca Limited Turns Around in Q1 FY27: Posts Profit Before Tax of INR 44.33 Million as Revenues Surge
  • Anthem Biosciences Limited Reports Q1 FY27 Net Profit of ₹1,199 Million on Revenues of ₹4,182 Million
  • ANVISA Approval for CuraTeQ Biologics' Biosimilars Manufacturing Facility
  • JSW Infrastructure Posts 18% Revenue Growth to ₹1,445 Crore in Q1 FY27; Operating EBITDA Reaches ₹674 Crore
  • TVS Holdings Reports Net Profit Jump of 73.8% to ₹1,173.58 Crore for Q1 FY27

Keywords Selected:  TrialRun

Stock Report

  • Rathi Steel and Power Ltd announces trial run of Hot Charging of Mild Steel Billets
  • Powering Growth: Rushil Décor Commences Trial RunProduction at Phase 2 of its State-of-the-Art JumboLaminate Plant
  • NHPC Ltd completes trial run of Unit 4 of Parbati-II HE project
  • SJVN Green Energy Ltd completes trial run of 241.77 MW capacity in Phase-I of Bikaner Solar Power Project
  • NHPC Ltd completes trial run of 3 units at Parbati-II HE project
  • NHPC Ltd completes trial run of Unit 2 of Parbati-II HE Project
  • Taylormade Renewables Ltd completes trial run at Coca-Cola, SABIC
  • Gulshan Polyols Limited updates on 250 KLPD grain based ethanol plant at Goalpara
  • Prism Johnson Ltd starts trial production at Panagarh greenfield project
  • Bigbloc Building Elements Pvt Ltd starts trial run of machineries for AAC Blocks project
  • TCM Ltd enters into temporary license deed agreement for trial run of cattle feed factory
  • Shree Cement Commences Trial Run of Clinkerisation Unit (Kiln-3) at Raipur, Chhattisgarh
  • Dynemic Products Limited starts trial run for Dye Intermediates at Dahej

Latest Post

  • Nureca Limited Turns Around in Q1 FY27: Posts Profit Before Tax of INR 44.33 Million as Revenues Surge
  • Anthem Biosciences Limited Reports Q1 FY27 Net Profit of ₹1,199 Million on Revenues of ₹4,182 Million
  • ANVISA Approval for CuraTeQ Biologics' Biosimilars Manufacturing Facility
  • JSW Infrastructure Posts 18% Revenue Growth to ₹1,445 Crore in Q1 FY27; Operating EBITDA Reaches ₹674 Crore
  • TVS Holdings Reports Net Profit Jump of 73.8% to ₹1,173.58 Crore for Q1 FY27


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025